Goblet cell carcinoid (GCC) is a rare and aggressive tumor of the appendix combining both neuroendocrine and adenocarcinoma features (hybrid tumor). Renamed 'goblet cell adenocarcinoma' in WHO 2019 classification. Unlike classic carcinoid, it shows diffuse infiltrative growth and may not form a focal mass. CT characteristically shows concentric wall thickening, periappendiceal stranding, and in advanced cases peritoneal spread.
Age Range
40-80
Peak Age
55
Gender
Equal
Prevalence
Rare
Goblet cell carcinoid originates from pluripotent stem cells at the appendiceal crypt base and shows both neuroendocrine differentiation (chromogranin A, synaptophysin positive) and mucinous glandular differentiation (goblet cells, mucin production). This dual phenotype places the tumor between classic carcinoid and adenocarcinoma. The tumor characteristically shows concentric infiltrative growth along the appendiceal wall — intramural spread frequently occurs without forming a distinct mass. This diffuse growth pattern manifests as concentric wall thickening on CT. In advanced stages, peritoneal spread is common (20-30%), and implants secreting mucinous material may create a pseudomyxoma peritonei-like picture. Prognosis is significantly worse than classic carcinoid (5-year survival 60-80% vs 95-99%).
On CT, concentric diffuse thickening of the appendiceal wall without forming a focal mass is the most characteristic finding of GCC. It is differentiated from the focal hypervascular nodule of classic carcinoid and the irregular-margined mass of adenocarcinoma by this pattern. Acute appendicitis findings may coexist and mask the tumor; when concentric thickening is noted, a pathological evaluation alert should be issued.
Concentric, smooth or mildly irregular thickening of the appendiceal wall is seen. Thickening is usually >5 mm affecting most or all of the appendix. Absence of focal mass formation is important in differential diagnosis from classic carcinoid and adenocarcinoma.
Report Sentence
Concentric wall thickening of the appendix is noted without a distinct focal mass.
Periappendiceal fat stranding and inflammatory changes are common in GCC because the tumor frequently presents as acute appendicitis. Inflammatory changes may mask the underlying tumor.
Report Sentence
Periappendiceal stranding and inflammatory changes accompany.
In advanced GCC, enhancing nodules (implants) on peritoneal surfaces and mucinous ascites may be seen. Omental caking, mesenteric nodularity, and implants in the pouch of Douglas are common locations. A pseudomyxoma peritonei-like picture may develop.
Report Sentence
Enhancing peritoneal implants and mucinous ascites are noted, consistent with peritoneal spread.
Appendiceal dilatation (>6 mm) may be seen due to luminal obstruction from GCC. Fluid or mucinous material accumulation may be seen proximal to the obstruction. In advanced cases, a mucocele-like appearance may occur.
Report Sentence
Appendiceal dilatation with mucinous content accumulation is noted; obstructive tumoral process should be considered.
On MRI, concentric thickening of intermediate signal intensity on T2-weighted sequences is seen in the appendiceal wall. Mucinous content shows high T2 signal. Post-contrast sequences demonstrate moderate wall enhancement. DWI diffusion restriction supports tumoral tissue.
Report Sentence
Concentric wall thickening and mucinous luminal content of the appendix on MRI is noted; goblet cell neoplasm should be considered.
On ultrasound, concentric hypoechoic thickening of the appendiceal wall is seen. Mucinous material within the lumen may appear hypoechoic or anechoic. Wall layers may be partially preserved but diffuse thickening predominates. Focal mass or nodule is typically not distinguishable.
Report Sentence
Concentric wall thickening and mucinous luminal content of the appendix on ultrasound is noted; neoplastic process should be considered.
Criteria
Well-differentiated goblet cell morphology, minimal solid growth, low mitotic activity
Distinct Features
Best prognosis (5-year survival ~100%). CT shows minimal wall thickening, usually incidental finding.
Criteria
Signet ring cell component >50%, solid growth, high mitotic activity, desmoplastic reaction
Distinct Features
Poor prognosis (5-year survival 25-50%). CT shows prominent wall thickening, peritoneal spread, LAP. Requires aggressive surgery + chemotherapy.
Distinguishing Feature
Classic carcinoid forms focal, well-defined hypervascular nodule (usually at tip); GCC shows diffuse concentric wall thickening without forming focal mass
Distinguishing Feature
Adenocarcinoma shows irregular-margined exophytic mass and luminal destruction; GCC shows dominant concentric thickening with minimal mass formation
Distinguishing Feature
In simple acute appendicitis, wall thickening is edematous and symmetric resolving with treatment; in GCC, thickening is solid/infiltrative and persistent, continuing after treatment
Urgency
urgentManagement
surgicalBiopsy
NeededFollow-up
6-monthGCC treatment should be more aggressive than classic carcinoid. Standard treatment is right hemicolectomy + peritoneal evaluation (for all stages). Appendectomy may be sufficient for Tang group A low-risk patients but remains controversial. In the presence of peritoneal spread, HIPEC (hyperthermic intraperitoneal chemotherapy) + cytoreductive surgery should be evaluated. Systemic chemotherapy (5-FU based) is applied in advanced disease. Follow-up: CT every 6 months for first 2 years, then annually. Serum CEA and CA-125 (for peritoneal spread) are used as follow-up markers.
Goblet cell carcinoid requires right hemicolectomy and peritoneal staging due to aggressive biological behavior. Tang classification (Groups A-C) determines prognosis and treatment: Group A (typical goblet cell) has best prognosis, Group C (signet ring/adenocarcinoma dominant) has worst prognosis. Peritoneal carcinomatosis is common and cytoreductive surgery + HIPEC should be considered. 5-year survival is 60-80% across all stages.